Meticulous Research®—a leading global market research company, published a research report titled, ‘NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic)—Global Forecast to 2030.’
According to this latest publication from Meticulous Research®, the NGS library preparation market is projected to reach $3.62 billion by 2030, at a CAGR of 14.8% from 2023 to 2030. The growth of this market is driven by the declining costs of sequencing, the rising prevalence of genetic disorders, the increasing utilization of NGS in diagnostics, and the increasing R&D investments and healthcare expenditure.
In addition, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for this market.
However, the expensive nature of NGS library preparation solutions in developing countries is expected to hinder the growth of this market to a certain extent. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the limited expertise and sequencing capabilities of mid and small-sized laboratories are the major challenges to market growth.
NGS Library Preparation Market: Future Outlook
The NGS library preparation market is segmented by product, application, sequencing type, end user, and geography. The study also evaluates industry competitors and analyzes the country and regional-level markets.
Based on product, in 2023, the reagents & consumables segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to factors such as the increasing demand for library preparation kits and reagents, the high number of research activities, and the numerous applications of NGS in different fields, such as drug and biomarker discovery and diagnostics.
Based on application, in 2023, the disease diagnostics segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the high prevalence of cancer globally, favorable reimbursement scenarios for NGS-based tests, and advancements in NGS-based oncology and non-invasive prenatal tests (NIPT).
Based on sequencing type, in 2023, the targeted sequencing segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the benefits offered by targeted sequencing, such as low cost, fast turnaround time, and accurate and easy interpretation of targeted sequencing results in the study of disease-related genes.
Based on end user, in 2023, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the high volume of NGS-based diagnostic tests performed in hospitals & diagnostic laboratories, the demand for advanced medical treatments, and the rising adoption of biomarker-based therapies.
This research report analyzes the market across major regions and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa.
In 2023, North America is expected to account for the largest share of the NGS library preparation market, followed by Europe and Asia-Pacific. North America’s major market is attributed to the factors such as governments’ increased support and investments to enhance genome sequencing infrastructure in the region, the increasing R&D investments by pharmaceutical and biopharmaceutical companies, and the presence of key market players in the region.
The key players operating in the NGS library preparation market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Beckman Coulter Inc. (U.S.) (Subsidiary of Danaher Corporation), Becton, Dickinson and Company (U.S.), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer Inc. (US), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (U.S.), Tecan Group Ltd. (Switzerland), Merck KGaA (Germany), and Integrated DNA Technologies, Inc. (U.S.).
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5319
Key questions answered in the report:
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More